Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Pneumococcal (Prevnar13)
  4. Hyporesponsive to stimuli
Pneumococcal (Prevnar13)×Hyporesponsive to stimuli

Hyporesponsive to stimuli Reports for Pneumococcal (Prevnar13)

#296 most reported symptom for this vaccine

62
Reports
1
Deaths
23
Hospitalizations
1.61
Mortality Rate
%
37.1
Hosp. Rate
%

Hyporesponsive to stimuli and Pneumococcal (Prevnar13)

Hyporesponsive to stimuli has been reported 62 times in association with Pneumococcal (Prevnar13) vaccination in VAERS. This represents 0.2% of all 33,058 reports for this vaccine.

Among these reports, 1 mentioned death (1.61%) and 23 involved hospitalization (37.1%).

Hyporesponsive to stimuli is the #296 most frequently reported symptom for Pneumococcal (Prevnar13) out of 1920 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 62 reports of Hyporesponsive to stimuli after Pneumococcal (Prevnar13) vaccination may seem alarming, but context is critical.

The mortality rate of 1.61% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.

Important Context

•Association, not causation: These reports show Hyporesponsive to stimuli occurred after vaccination, not that the vaccine caused it.
•Background rates: Hyporesponsive to stimuli may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Swollen tongue62 reportsSkin reaction62 reportsEyelid oedema61 reportsRetching61 reports

Quick Facts

Reports:62
Deaths:1
Hospitalizations:23
% of Vaccine:0.2%
Rank:#296 of 1920

Related Pages

Pneumococcal (Prevnar13) OverviewHyporesponsive to stimuli (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.